Published in Autism Res Treat on March 05, 2012
Decreased Epidermal Growth Factor (EGF) Associated with HMGB1 and Increased Hyperactivity in Children with Autism. Biomark Insights (2013) 0.81
Increased Epidermal Growth Factor Receptor (EGFR) Associated with Hepatocyte Growth Factor (HGF) and Symptom Severity in Children with Autism Spectrum Disorders (ASDs). J Cent Nerv Syst Dis (2014) 0.79
Abnormalities in the zinc-metalloprotease-BDNF axis may contribute to megalencephaly and cortical hyperconnectivity in young autism spectrum disorder patients. Mol Brain (2014) 0.79
Persistent astrocyte activation in the fragile X mouse cerebellum. Brain Behav (2015) 0.79
Decreased Phosphorylated Protein Kinase B (Akt) in Individuals with Autism Associated with High Epidermal Growth Factor Receptor (EGFR) and Low Gamma-Aminobutyric Acid (GABA). Biomark Insights (2015) 0.75
Peripheral Inflammatory Markers Contributing to Comorbidities in Autism. Behav Sci (Basel) (2016) 0.75
Serum and cerebrospinal fluid immune mediators in children with autistic disorder: a longitudinal study. Mol Autism (2017) 0.75
Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord (1994) 42.80
Autism diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord (1989) 7.53
Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ (2009) 7.02
Autism screening questionnaire: diagnostic validity. Br J Psychiatry (1999) 6.61
Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol (2005) 5.95
Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature (1995) 4.56
Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. N Engl J Med (2003) 3.49
In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain. J Neurosci (1996) 2.72
Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends Neurosci (2004) 2.50
Elevated immune response in the brain of autistic patients. J Neuroimmunol (2009) 2.46
Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun (2010) 2.44
Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol (2007) 2.02
Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun (2009) 1.86
Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. J Biol Chem (1992) 1.58
Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine--United States, 1997-2006. MMWR Morb Mortal Wkly Rep (2009) 1.54
Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J Neuroimmunol (2006) 1.53
Altered T cell responses in children with autism. Brain Behav Immun (2010) 1.53
A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J Immunol (2005) 1.49
Neurotrophins and the immune system. J Anat (2003) 1.46
Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol (2003) 1.28
Immune dysfunction in autism: a pathway to treatment. Neurotherapeutics (2010) 1.22
Interactions between the cells of the immune and nervous system: neurotrophins as neuroprotection mediators in CNS injury. Prog Brain Res (2004) 1.22
Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol (2004) 1.21
Autism and gastrointestinal symptoms. Curr Gastroenterol Rep (2002) 1.16
Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma. Clin Endocrinol (Oxf) (2000) 0.96
"Phenome" project set to pin down subgroups of autism. Nat Med (2005) 0.95
SNP analyses of growth factor genes EGF, TGFbeta-1, and HGF reveal haplotypic association of EGF with autism. Biochem Biophys Res Commun (2007) 0.92
EGF family of growth factors: essential roles and functional redundancy in the nerve system. Front Biosci (2004) 0.91
Entry of EGF into brain is rapid and saturable. Peptides (1999) 0.90
Roles of transforming growth factor-alpha and related molecules in the nervous system. Mol Neurobiol (2000) 0.90
The role of neurotrophic factors in autism. Mol Psychiatry (2010) 0.90
Epidermal growth factor for ulcerative colitis. N Engl J Med (2003) 0.87
Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin. Expert Rev Dermatol (2008) 0.86
Decreased serum levels of epidermal growth factor in adult subjects with high-functioning autism. Biol Psychiatry (2006) 0.86
Decreased serum levels of hepatocyte growth factor in male adults with high-functioning autism. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.81
The immune response in autism: a new frontier for autism research. J Leukoc Biol (2006) 2.65
Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav Immun (2008) 2.50
Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun (2010) 2.44
Concern The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. Eur J Gastroenterol Hepatol (2005) 2.41
Consensus paper: pathological role of the cerebellum in autism. Cerebellum (2012) 2.32
The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun (2011) 2.24
Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med (2002) 2.00
Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology (2007) 1.87
Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun (2009) 1.86
The human placenta methylome. Proc Natl Acad Sci U S A (2013) 1.86
Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch Pediatr Adolesc Med (2005) 1.81
Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav Immun (2008) 1.79
Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest (2002) 1.65
Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann N Y Acad Sci (2007) 1.55
Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology (2009) 1.55
Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol Psychiatry (2008) 1.54
Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology (2010) 1.53
Altered T cell responses in children with autism. Brain Behav Immun (2010) 1.53
Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study. Mol Autism (2011) 1.51
Autoimmunity in autism. Curr Opin Investig Drugs (2009) 1.49
Ultra Low Density and Highly Crosslinked Biocompatible Shape Memory Polyurethane Foams. J Polym Sci B Polym Phys (2012) 1.48
Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol (2010) 1.46
Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol (2008) 1.41
Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome. Genomics (2006) 1.39
Is autism an autoimmune disease? Autoimmun Rev (2004) 1.37
Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res (2008) 1.37
Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology (2005) 1.37
Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain Behav Immun (2008) 1.34
Increased IgG4 levels in children with autism disorder. Brain Behav Immun (2008) 1.32
The immune system's role in the biology of autism. Curr Opin Neurol (2010) 1.31
Immune dysfunction in autism: a pathway to treatment. Neurotherapeutics (2010) 1.22
Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol (2003) 1.21
Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. Neurotoxicol Teratol (2012) 1.21
MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res (2008) 1.19
Genetic and immunologic considerations in autism. Neurobiol Dis (2002) 1.19
Immunological and autoimmune considerations of Autism Spectrum Disorders. J Autoimmun (2013) 1.17
A review of autism and the immune response. Clin Dev Immunol (2004) 1.15
Autoantibodies in autism spectrum disorders (ASD). Ann N Y Acad Sci (2007) 1.11
Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders. J Neuroimmunol (2009) 1.11
Behavioral correlates of maternal antibody status among children with autism. J Autism Dev Disord (2012) 1.11
Gastrointestinal conditions in children with autism spectrum disorder: developing a research agenda. Pediatrics (2012) 1.08
Maternal autoantibodies in autism. Arch Neurol (2012) 1.08
Autoantibodies to cerebellum in children with autism associate with behavior. Brain Behav Immun (2010) 1.07
A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disord (2011) 1.06
Exposure to air pollution in critical prenatal time windows and IgE levels in newborns. Pediatr Allergy Immunol (2011) 1.04
Immune-mediated disorders among women carriers of fragile X premutation alleles. Am J Med Genet A (2012) 1.04
In search of cellular immunophenotypes in the blood of children with autism. PLoS One (2011) 1.04
Air pollution exposure during critical time periods in gestation and alterations in cord blood lymphocyte distribution: a cohort of livebirths. Environ Health (2010) 1.03
Identifying environmental contributions to autism: provocative clues and false leads. Ment Retard Dev Disabil Res Rev (2004) 1.00
Reduced transforming growth factor-beta1-producing T cells in the duodenal mucosa of children with food allergy. Eur J Immunol (2003) 0.99
Maternal autism-associated IgG antibodies delay development and produce anxiety in a mouse gestational transfer model. J Neuroimmunol (2012) 0.98
Focal-enhanced gastritis in regressive autism with features distinct from Crohn's and Helicobacter pylori gastritis. Am J Gastroenterol (2004) 0.98
Polyurethane shape-memory polymers demonstrate functional biocompatibility in vitro. Macromol Biosci (2007) 0.98
Air pollution and lymphocyte phenotype proportions in cord blood. Environ Health Perspect (2005) 0.97
Antimitochondrial antibodies in primary biliary cirrhosis: the role of xenobiotics. Autoimmun Rev (2002) 0.96
The potential role of probiotics in the management of childhood autism spectrum disorders. Gastroenterol Res Pract (2011) 0.96
Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder. Brain Behav Immun (2013) 0.95
Brain-derived neurotrophic factor and autism: maternal and infant peripheral blood levels in the Early Markers for Autism (EMA) Study. Autism Res (2008) 0.93
Correlations of gene expression with blood lead levels in children with autism compared to typically developing controls. Neurotox Res (2009) 0.93
Brief report: plasma leptin levels are elevated in autism: association with early onset phenotype? J Autism Dev Disord (2007) 0.93
Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome. Hum Genet (2010) 0.92
Increased anti-phospholipid antibodies in autism spectrum disorders. Mediators Inflamm (2013) 0.92
Maternal immune-mediated conditions, autism spectrum disorders, and developmental delay. J Autism Dev Disord (2014) 0.91
B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage. Autoimmun Rev (2007) 0.90
Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. J Transl Med (2013) 0.89
Detection of plasma autoantibodies to brain tissue in young children with and without autism spectrum disorders. Brain Behav Immun (2011) 0.88
The role of dietary microparticles and calcium in apoptosis and interleukin-1beta release of intestinal macrophages. Gastroenterology (2002) 0.88
Inflammatory macrophage phenotype in BTBR T+tf/J mice. Front Neurosci (2013) 0.88
Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis. Gastroenterology (2003) 0.86
Elevated expression of tyrosine kinase DDR2 in primary biliary cirrhosis. Autoimmunity (2002) 0.86
Maternal and fetal antibrain antibodies in development and disease. Dev Neurobiol (2012) 0.86
Autism spectrum disorders: from immunity to behavior. Methods Mol Biol (2012) 0.85
Myeloid dendritic cells frequencies are increased in children with autism spectrum disorder and associated with amygdala volume and repetitive behaviors. Brain Behav Immun (2012) 0.85
Correlations between gene expression and mercury levels in blood of boys with and without autism. Neurotox Res (2009) 0.84
Levels of soluble platelet endothelial cell adhesion molecule-1 and P-selectin are decreased in children with autism spectrum disorder. Biol Psychiatry (2012) 0.84
Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study. J Neuroinflammation (2014) 0.84
Preliminary evidence of the in vitro effects of BDE-47 on innate immune responses in children with autism spectrum disorders. J Neuroimmunol (2009) 0.83
Decreased levels of total immunoglobulin in children with autism are not a result of B cell dysfunction. J Neuroimmunol (2012) 0.82
Gestational exposure to a viral mimetic poly(i:C) results in long-lasting changes in mitochondrial function by leucocytes in the adult offspring. Mediators Inflamm (2013) 0.82
Women and primary biliary cirrhosis. Clin Rev Allergy Immunol (2015) 0.81